segunda-feira, outubro 30, 2006
Novo Kaletra bem tolerado
Aidsmap 27.10.06
People taking Kaletra (lopinavir/ritonavir) prefer the new tablet version - taken once a day - over the soft gel capsules taken twice a day according to data from a small US study presented at the recent Eighth International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV in San Francisco. Until recently Kaletra was supplied as a soft-gel capsule and three were taken twice daily with meals. The capsules also had to be kept refrigerated.
(...)
People taking Kaletra (lopinavir/ritonavir) prefer the new tablet version - taken once a day - over the soft gel capsules taken twice a day according to data from a small US study presented at the recent Eighth International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV in San Francisco. Until recently Kaletra was supplied as a soft-gel capsule and three were taken twice daily with meals. The capsules also had to be kept refrigerated.
(...)
